Shandong Boan Biotechnology Co (HKSE:06955) Equity-to-Asset : 0.57 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Shandong Boan Biotechnology Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,443.6 Mil. Shandong Boan Biotechnology Co's Total Assets for the quarter that ended in Dec. 2023 was HK$2,541.3 Mil. Therefore, Shandong Boan Biotechnology Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.57.

The historical rank and industry rank for Shandong Boan Biotechnology Co's Equity-to-Asset or its related term are showing as below:

HKSE:06955' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.53 Med: 0.61 Max: 0.74
Current: 0.57

During the past 4 years, the highest Equity to Asset Ratio of Shandong Boan Biotechnology Co was 0.74. The lowest was 0.53. And the median was 0.61.

HKSE:06955's Equity-to-Asset is ranked worse than
58.33% of 1567 companies
in the Biotechnology industry
Industry Median: 0.66 vs HKSE:06955: 0.57

Shandong Boan Biotechnology Co Equity-to-Asset Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Equity-to-Asset Chart

Shandong Boan Biotechnology Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

0.53

0.74

0.64

0.57

Shandong Boan Biotechnology Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			0.74	0.70	0.64	0.61	0.57

Competitive Comparison of Shandong Boan Biotechnology Co's Equity-to-Asset

For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Boan Biotechnology Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Shandong Boan Biotechnology Co's Equity-to-Asset falls into.

Shandong Boan Biotechnology Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Shandong Boan Biotechnology Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	1443.644	/	2541.271
	=	0.57

Shandong Boan Biotechnology Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	1443.644	/	2541.271
	=	0.57

Shandong Boan Biotechnology Co (HKSE:06955) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Shandong Boan Biotechnology Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

UJ9:Germany

Address

No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN

Website

https://www.boan-bio.com

Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines